Accounts Payable and Related Party (Tables)

12 Months Ended

Dec. 31, 2024

Payables and Accruals [Abstract]

Schedule of Accounts Payable

Accounts payable consists of the following:

	As of					As of
	December 31, 2024		%			December 31, 2023		%
Accounts payable to Cytovance, a related party 1	$	1,183,000		31	%	$	3,515,000		81	%
Accounts payable to University of Minnesota		712,000		18	%		121,000		3	%
Legal services firm		1,505,000		39	%		130,000		3	%
Other accounts payable		453,000		12	%		562,000		13	%
Total accounts payable	$	3,853,000				$	4,328,000

¹ Accounts Payable to Cytovance Biologics, Inc. (“Cytovance”), a Related Party, since Cytovance owns greater than 5% of the Company’s issued and outstanding common stock. See Note 8 – Commitments and Contingencies, Significant Agreements.

Schedule of Accounts Payable to Related Party

The details of the Company’s accounts payable to Cytovance Biologics, Inc., were as follows:

	Year Ending
	December 31, 2024			December 31, 2023
Beginning balance	$	3,515,000		$	2,264,000
Invoices, net		2,335,000			4,584,000
Payments in cash		(3,857,000	)		(2,213,000	)
Payments in common stock, at fair value		(810,000	)		(1,120,000	)
Ending balance	$	1,183,000		$	3,515,000